Spyre Therapeutics, Inc.

This study tests whether long-acting antibodies can help people with moderate to severe ulcerative colitis (UC). About 645 adults will receive the antibodies through an IV and then as shots under the skin. The goal is to see if these treatments reduce gut inflammation and lead to…

This study tests an experimental drug called SPY002-072 in 285 adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. Participants receive either the drug or a placebo to see if it reduces joint pain, swelling, and inflamm…